MDLN – Medline Inc

MDLN — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

2.57

Margin Of Safety %

Put/Call OI Ratio

0.26

EPS Next Q Diff

0.34

EPS Last/This Y

0.04

EPS This/Next Y

0.19

Price

42.63

Target Price

53.77

Analyst Recom

1.48

Performance Q

-3.42

Upside

-25.2%

Beta

Ticker: MDLN

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	MDLN	43.4	0.23	0.22	41873
2026-03-10	MDLN	42.85	0.23	0.58	41409
2026-03-11	MDLN	42.35	0.24	0.08	41787
2026-03-12	MDLN	41.06	0.24	0.88	41825
2026-03-13	MDLN	41.07	0.24	0.87	41825
2026-03-17	MDLN	42.17	0.25	0.88	42721
2026-03-18	MDLN	42.23	0.25	0.19	42715
2026-03-19	MDLN	43.57	0.25	0.20	42809
2026-03-20	MDLN	42.69	0.25	0.87	43175
2026-03-23	MDLN	42.42	0.31	0.00	15844
2026-03-24	MDLN	42.04	0.14	0.89	31045
2026-03-25	MDLN	42.46	0.15	0.17	31212
2026-03-26	MDLN	42.19	0.15	0.05	31320
2026-03-27	MDLN	41.4	0.15	2.14	31355
2026-03-30	MDLN	42.63	0.26	0.60	36757
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

15 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	MDLN	43.42	-	527.7	-
2026-03-10	MDLN	42.84	-	519.7	-
2026-03-11	MDLN	42.36	-	521.8	-
2026-03-12	MDLN	41.06	-	483.3	-
2026-03-13	MDLN	41.44	-	564.2	1.47
2026-03-17	MDLN	42.18	-	566.4	1.47
2026-03-18	MDLN	42.23	-	549.3	1.47
2026-03-19	MDLN	43.58	-	609.2	1.47
2026-03-20	MDLN	42.69	-	504.6	1.47
2026-03-23	MDLN	42.42	-	533.2	1.47
2026-03-24	MDLN	42.03	-	524.9	1.47
2026-03-25	MDLN	42.65	-	575.2	1.47
2026-03-26	MDLN	42.24	-	525.9	1.47
2026-03-27	MDLN	41.35	-	505.5	1.47
2026-03-30	MDLN	42.63	-	606.7	1.47
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

15 items 1 of 1

15 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	MDLN	-10.60	-5.30	1.62
2026-03-10	MDLN	-10.60	-5.30	1.62
2026-03-11	MDLN	-10.60	-5.30	1.82
2026-03-12	MDLN	-28.17	-5.30	1.82
2026-03-13	MDLN	-30.40	-5.30	1.82
2026-03-17	MDLN	-30.40	-5.30	1.82
2026-03-18	MDLN	-30.40	-5.30	1.82
2026-03-19	MDLN	-30.40	-5.30	1.82
2026-03-20	MDLN	-30.40	-5.30	1.82
2026-03-23	MDLN	-30.40	4.61	1.82
2026-03-24	MDLN	-30.40	4.61	1.82
2026-03-25	MDLN	-30.40	4.61	2.57
2026-03-26	MDLN	-30.40	4.61	2.57
2026-03-27	MDLN	-30.40	4.61	2.57
2026-03-30	MDLN	-30.40	24.96	2.57
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

15 items 1 of 1

Last Quarter Act. EPS

-0.01

Avg. EPS Est. Current Quarter

0.29

Avg. EPS Est. Next Quarter

0.33

Insider Transactions

-30.4

Institutional Transactions

24.96

Beta

Average Sales Estimate Current Quarter

7162

Average Sales Estimate Next Quarter

7488

Fair Value

48.2

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

16.2

Max Drawdown 5-Year %

Target Price

53.77

P/E

29.48

Forward P/E

25.77

PEG

2.67

P/S

1.97

P/B

3.22

P/Free Cash Flow

44.3

EPS

1.45

Average EPS Est. Cur. Y

1.47

EPS Next Y. (Est.)

1.66

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.08

Relative Volume

1.55

Return on Equity vs Sector %

-16.6

Return on Equity vs Industry %

1.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

606.7

◆ MDLN Healthcare

$42.62

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

17/25

Volume

3/15

Valuation

14/20

TP/AR

2/10

Options

6/10

RSI

46.5

Range 1M

23.7%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

11/30

Estimates

2/20

Inst/Vol

8/15

Options

9/10

EPS Yr

2.8%

EPS NY

12.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +2% upside

Quality

3/30

Valuation

4/30

Growth

7/25

Stability

4/10

LT Trend

0/5

Upside

+2%

Quality

MoS

13%

Medline Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 45000

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

MDLN

Latest News

—

Caricamento notizie per MDLN…

stock quote shares MDLN – Medline Inc Stock Price stock today

news today MDLN – Medline Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch MDLN – Medline Inc yahoo finance google finance

stock history MDLN – Medline Inc invest stock market

stock prices MDLN premarket after hours

ticker MDLN fair value insiders trading

SOLV – Solventum Corp

SOLV — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

2.69

Margin Of Safety %

Put/Call OI Ratio

0.31

EPS Next Q Diff

1.3

EPS Last/This Y

-2.48

EPS This/Next Y

0.58

Price

63.43

Target Price

Analyst Recom

2.6

Performance Q

-21.14

Upside

207.5%

Beta

0.89

Ticker: SOLV

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	SOLV	68.56	0.45	20.63	8085
2026-03-10	SOLV	67.62	0.46	0.50	8100
2026-03-11	SOLV	67.58	0.46	1.00	8094
2026-03-12	SOLV	66.15	0.47	0.45	8129
2026-03-13	SOLV	66.12	0.47	0.73	8129
2026-03-17	SOLV	68.67	0.37	0.08	7677
2026-03-18	SOLV	67.11	0.36	0.12	7886
2026-03-19	SOLV	67.14	0.36	0.77	7886
2026-03-20	SOLV	65.77	0.33	0.76	7768
2026-03-23	SOLV	65.69	0.32	0.02	6706
2026-03-24	SOLV	64.03	0.29	0.85	6981
2026-03-25	SOLV	64.6	0.30	0.36	7158
2026-03-26	SOLV	64.73	0.30	0.52	7360
2026-03-27	SOLV	62.76	0.30	0.84	7384
2026-03-30	SOLV	63.47	0.31	0.11	7451
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

15 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	SOLV	68.60	0.7	-783.5	6.47
2026-03-10	SOLV	67.65	0.7	-785.6	6.47
2026-03-11	SOLV	67.62	0.7	-772.1	6.47
2026-03-12	SOLV	66.18	0.7	-792.6	6.47
2026-03-13	SOLV	66.74	0.7	-763.5	6.47
2026-03-17	SOLV	68.67	0.7	-750.8	6.47
2026-03-18	SOLV	67.09	0.7	-794.4	6.47
2026-03-19	SOLV	67.15	0.7	-1330.6	6.47
2026-03-20	SOLV	65.78	0.7	-1341.9	6.47
2026-03-23	SOLV	65.71	0.7	-1331.6	6.47
2026-03-24	SOLV	64.03	0.7	-1344.5	6.47
2026-03-25	SOLV	64.61	0.7	-1326.3	6.47
2026-03-26	SOLV	64.75	0.7	-1330.1	6.47
2026-03-27	SOLV	62.76	0.9	-1347.1	6.46
2026-03-30	SOLV	63.43	0.9	-1325.4	6.46
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

15 items 1 of 1

16 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-06	SOLV	0.00	1.49	2.40
2026-03-09	SOLV	0.00	1.48	2.40
2026-03-10	SOLV	0.00	1.48	2.40
2026-03-11	SOLV	0.01	1.48	2.36
2026-03-12	SOLV	0.01	1.48	2.36
2026-03-13	SOLV	0.01	1.48	2.36
2026-03-17	SOLV	0.01	1.49	2.36
2026-03-18	SOLV	0.01	1.49	2.36
2026-03-19	SOLV	0.01	1.49	2.36
2026-03-20	SOLV	0.01	1.49	2.36
2026-03-23	SOLV	0.01	1.54	2.36
2026-03-24	SOLV	0.01	1.54	2.36
2026-03-25	SOLV	0.01	1.54	2.69
2026-03-26	SOLV	0.01	1.54	2.69
2026-03-27	SOLV	0.01	1.54	2.69
2026-03-30	SOLV	0.01	1.52	2.69
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

16 items 1 of 1

Last Quarter Act. EPS

0.36

Avg. EPS Est. Current Quarter

1.35

Avg. EPS Est. Next Quarter

1.66

Insider Transactions

0.01

Institutional Transactions

1.52

Beta

0.89

Average Sales Estimate Current Quarter

1968

Average Sales Estimate Next Quarter

2069

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

7.15

Forward P/E

9.04

PEG

1.11

P/S

1.32

P/B

2.18

P/Free Cash Flow

EPS

8.87

Average EPS Est. Cur. Y

6.46

EPS Next Y. (Est.)

7.04

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

18.64

Relative Volume

1.31

Return on Equity vs Sector %

3.4

Return on Equity vs Industry %

21.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.12

EBIT Estimation

-1325.4

◆ SOLV Healthcare

$63.45

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

10/20

Pullback

21/25

Volume

3/15

Valuation

15/20

TP/AR

0/10

Options

6/10

RSI

30.9

Range 1M

6.1%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

7/30

Estimates

5/20

Inst/Vol

5/15

Options

10/10

EPS Yr

EPS NY

8.5%

52W%

9.6%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +114% upside

Quality

24/30

Valuation

19/30

Growth

7/25

Stability

3/10

LT Trend

4/5

Upside

+114%

Quality

Solventum Corporation

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 20584

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

SOLV

Latest News

—

Caricamento notizie per SOLV…

stock quote shares SOLV – Solventum Corp Stock Price stock today

news today SOLV – Solventum Corp stock forecast ,stock prediction 2023 2024 2025

marketwatch SOLV – Solventum Corp yahoo finance google finance

stock history SOLV – Solventum Corp invest stock market

stock prices SOLV premarket after hours

ticker SOLV fair value insiders trading

STXS – Stereotaxis Inc.

STXS — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

4.16

Margin Of Safety %

Put/Call OI Ratio

0.08

EPS Next Q Diff

0.01

EPS Last/This Y

0.06

EPS This/Next Y

0.06

Price

1.78

Target Price

4.2

Analyst Recom

Performance Q

-27.64

Upside

-591.6%

Beta

1.42

Ticker: STXS

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	STXS	2.22	0.08	0.00	5482
2026-03-03	STXS	2.14	0.08	0.00	5484
2026-03-04	STXS	2.22	0.08	0.00	5484
2026-03-05	STXS	2.21	0.08	0.00	5484
2026-03-06	STXS	2.06	0.08	0.00	5486
2026-03-09	STXS	2.08	0.08	999.99	5492
2026-03-10	STXS	1.97	0.08	0.33	5493
2026-03-11	STXS	1.92	0.08	3.00	5498
2026-03-12	STXS	1.88	0.08	3.00	5498
2026-03-13	STXS	1.88	0.08	3.00	5498
2026-03-17	STXS	1.9	0.04	999.99	5432
2026-03-18	STXS	1.8	0.04	999.99	5443
2026-03-19	STXS	1.815	0.05	0.60	5467
2026-03-20	STXS	1.785	0.05	2.75	5466
2026-03-23	STXS	1.835	0.06	0.00	5123
2026-03-24	STXS	1.805	0.06	0.00	5162
2026-03-25	STXS	1.875	0.06	0.00	5154
2026-03-26	STXS	1.885	0.06	0.90	5171
2026-03-27	STXS	1.8	0.07	0.84	5225
2026-03-30	STXS	1.78	0.08	0.05	5301
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	STXS	2.22	27.8	-	-0.26
2026-03-03	STXS	2.14	27.8	-	-0.26
2026-03-04	STXS	2.22	27.8	-	-0.26
2026-03-05	STXS	2.21	27.8	-	-0.26
2026-03-06	STXS	2.05	27.8	-	-0.26
2026-03-09	STXS	2.07	27.8	-	-0.26
2026-03-10	STXS	1.98	27.8	-	-0.26
2026-03-11	STXS	1.93	27.8	-	-0.26
2026-03-12	STXS	1.88	27.8	-	-0.26
2026-03-13	STXS	1.89	28.6	-	-0.18
2026-03-17	STXS	1.90	28.6	-	-0.18
2026-03-18	STXS	1.80	28.6	-	-0.18
2026-03-19	STXS	1.81	28.6	-	-0.18
2026-03-20	STXS	1.78	28.6	-	-0.18
2026-03-23	STXS	1.84	28.6	-	-0.18
2026-03-24	STXS	1.80	28.6	-	-0.18
2026-03-25	STXS	1.88	28.6	-	-0.18
2026-03-26	STXS	1.89	28.6	-	-0.18
2026-03-27	STXS	1.80	28.6	-	-0.18
2026-03-30	STXS	1.78	28.6	-	-0.18
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	STXS	0.19	0.29	4.22
2026-03-03	STXS	0.19	0.29	4.22
2026-03-04	STXS	0.19	0.29	4.22
2026-03-05	STXS	0.19	0.29	4.22
2026-03-06	STXS	0.19	0.29	4.22
2026-03-09	STXS	0.19	0.27	4.22
2026-03-10	STXS	0.19	0.27	4.22
2026-03-11	STXS	0.19	0.27	3.88
2026-03-12	STXS	0.19	0.27	3.88
2026-03-13	STXS	0.19	0.27	3.88
2026-03-17	STXS	0.18	0.28	3.73
2026-03-18	STXS	0.18	0.28	3.73
2026-03-19	STXS	0.18	0.28	3.73
2026-03-20	STXS	0.18	0.28	3.73
2026-03-23	STXS	0.18	0.28	3.73
2026-03-24	STXS	0.18	0.28	3.73
2026-03-25	STXS	0.18	0.28	4.16
2026-03-26	STXS	0.18	0.28	4.16
2026-03-27	STXS	0.18	0.28	4.16
2026-03-30	STXS	0.18	0.28	4.16
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.06

Avg. EPS Est. Current Quarter

-0.05

Avg. EPS Est. Next Quarter

-0.05

Insider Transactions

0.18

Institutional Transactions

0.28

Beta

1.42

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

82.7

Max Drawdown 5-Year %

-86

Target Price

4.2

P/E

Forward P/E

PEG

P/S

5.35

P/B

12.59

P/Free Cash Flow

EPS

-0.25

Average EPS Est. Cur. Y

-0.18

EPS Next Y. (Est.)

-0.12

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-70.78

Relative Volume

0.87

Return on Equity vs Sector %

-149.8

Return on Equity vs Industry %

-131.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ STXS Healthcare

$1.78

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

21/25

Volume

7/15

Valuation

12/20

TP/AR

2/10

Options

7/10

RSI

36.1

Range 1M

7.4%

Sup Dist

0.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

22/30

Estimates

1/20

Inst/Vol

2/15

Options

10/10

EPS Yr

24%

EPS NY

32.6%

52W%

12%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +136% upside

Quality

6/30

Valuation

16/30

Growth

17/25

Stability

5/10

LT Trend

4/5

Upside

+136%

Quality

Stereotaxis, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 131

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

STXS

Latest News

—

Caricamento notizie per STXS…

stock quote shares STXS – Stereotaxis Inc. Stock Price stock today

news today STXS – Stereotaxis Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch STXS – Stereotaxis Inc. yahoo finance google finance

stock history STXS – Stereotaxis Inc. invest stock market

stock prices STXS premarket after hours

ticker STXS fair value insiders trading

OSUR – OraSure Technologies Inc.

OSUR — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

5.4

Margin Of Safety %

Put/Call OI Ratio

0.02

EPS Next Q Diff

0.07

EPS Last/This Y

0.38

EPS This/Next Y

0.09

Price

2.93

Target Price

Analyst Recom

Performance Q

20.66

Upside

-808.2%

Beta

0.83

Ticker: OSUR

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	OSUR	2.95	0.03	0.00	5680
2026-03-03	OSUR	2.98	0.03	0.00	5685
2026-03-04	OSUR	3.01	0.03	0.00	5712
2026-03-05	OSUR	2.99	0.03	0.00	5754
2026-03-06	OSUR	3.19	0.03	0.00	5744
2026-03-09	OSUR	3.2	0.03	0.00	5736
2026-03-10	OSUR	3.14	0.03	0.00	5736
2026-03-11	OSUR	3.19	0.03	0.00	5720
2026-03-12	OSUR	3.1	0.03	999.99	5763
2026-03-13	OSUR	3.09	0.03	999.99	5763
2026-03-17	OSUR	2.99	0.03	0.00	6323
2026-03-18	OSUR	2.91	0.03	0.04	6484
2026-03-19	OSUR	2.92	0.03	0.04	6484
2026-03-20	OSUR	2.95	0.03	0.00	7037
2026-03-23	OSUR	3.08	0.02	0.00	8711
2026-03-24	OSUR	3.07	0.02	5.25	8701
2026-03-25	OSUR	3.14	0.02	0.00	8720
2026-03-26	OSUR	3.06	0.02	999.99	8767
2026-03-27	OSUR	3	0.02	999.99	8777
2026-03-30	OSUR	2.92	0.02	1.00	8777
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	OSUR	2.96	21.6	-	-0.45
2026-03-03	OSUR	2.98	21.6	-	-0.45
2026-03-04	OSUR	3.01	21.6	-	-0.45
2026-03-05	OSUR	2.99	21.6	-	-0.45
2026-03-06	OSUR	3.20	21.6	-	-0.45
2026-03-09	OSUR	3.20	9.1	-	-0.56
2026-03-10	OSUR	3.13	9.1	-	-0.56
2026-03-11	OSUR	3.19	9.1	-	-0.56
2026-03-12	OSUR	3.10	9.1	-	-0.56
2026-03-13	OSUR	2.98	9.1	-	-0.56
2026-03-17	OSUR	2.99	9.1	-	-0.56
2026-03-18	OSUR	2.91	9.1	-	-0.56
2026-03-19	OSUR	2.92	9.1	-	-0.56
2026-03-20	OSUR	2.95	9.1	-	-0.56
2026-03-23	OSUR	3.08	9.1	-	-0.56
2026-03-24	OSUR	3.06	9.1	-	-0.56
2026-03-25	OSUR	3.14	9.1	-	-0.56
2026-03-26	OSUR	3.06	9.1	-	-0.56
2026-03-27	OSUR	3.00	9.1	-	-0.56
2026-03-30	OSUR	2.93	9.1	-	-0.56
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	OSUR	0.05	-3.52	5.94
2026-03-03	OSUR	0.05	-3.52	5.94
2026-03-04	OSUR	0.05	-3.52	5.94
2026-03-05	OSUR	0.05	-3.52	5.94
2026-03-06	OSUR	0.05	-3.52	5.94
2026-03-09	OSUR	0.05	-3.58	5.94
2026-03-10	OSUR	0.05	-3.58	5.94
2026-03-11	OSUR	0.05	-3.58	5.65
2026-03-12	OSUR	0.05	-3.58	5.87
2026-03-13	OSUR	0.05	-3.58	5.87
2026-03-17	OSUR	1.18	-3.61	5.87
2026-03-18	OSUR	1.18	-3.61	5.87
2026-03-19	OSUR	1.18	-3.61	5.87
2026-03-20	OSUR	1.18	-3.61	5.87
2026-03-23	OSUR	1.18	-3.61	5.87
2026-03-24	OSUR	2.89	-3.61	5.87
2026-03-25	OSUR	2.89	-3.61	5.40
2026-03-26	OSUR	2.89	-3.61	5.40
2026-03-27	OSUR	2.89	-3.61	5.40
2026-03-30	OSUR	2.89	-3.62	5.40
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.16

Avg. EPS Est. Next Quarter

-0.14

Insider Transactions

2.89

Institutional Transactions

-3.62

Beta

0.83

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

78.4

Max Drawdown 5-Year %

-84.2

Target Price

P/E

Forward P/E

PEG

P/S

1.75

P/B

0.6

P/Free Cash Flow

EPS

-0.94

Average EPS Est. Cur. Y

-0.56

EPS Next Y. (Est.)

-0.47

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-59.76

Relative Volume

0.73

Return on Equity vs Sector %

-47.6

Return on Equity vs Industry %

-29.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

◆ OSUR Healthcare

$2.92

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

2/20

Pullback

18/25

Volume

9/15

Valuation

12/20

TP/AR

1/10

Options

7/10

RSI

46.8

Range 1M

18.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

10/30

Estimates

0/20

Inst/Vol

3/15

Options

5/10

EPS Yr

15.4%

EPS NY

10.7%

52W%

47.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +71.2% upside

Quality

5/30

Valuation

14/30

Growth

5/25

Stability

8/10

LT Trend

1/5

Upside

+71.2%

Quality

OraSure Technologies, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 500

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. The company also provides genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of urine samples; and HEMAcollect protein blood collection device. In addition, it provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, it offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, it develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. It sells its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, and companion animal, markets. The company was founded in 1987 and is headquartered in Bethlehem, Pennsylvania.

OSUR

Latest News

—

Caricamento notizie per OSUR…

stock quote shares OSUR – OraSure Technologies Inc. Stock Price stock today

news today OSUR – OraSure Technologies Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch OSUR – OraSure Technologies Inc. yahoo finance google finance

stock history OSUR – OraSure Technologies Inc. invest stock market

stock prices OSUR premarket after hours

ticker OSUR fair value insiders trading

EKSO – Ekso Bionics Holdings Inc.

EKSO — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

10.03

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

1.41

EPS Last/This Y

4.47

EPS This/Next Y

0.37

Price

10.04

Target Price

49.75

Analyst Recom

Performance Q

80.4

Upside

-1,865.7%

Beta

0.78

Ticker: EKSO

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	EKSO	10.01	N/A	N/A	0
2026-03-03	EKSO	10	N/A	N/A	0
2026-03-04	EKSO	10.79	N/A	N/A	0
2026-03-05	EKSO	10.83	N/A	N/A	0
2026-03-06	EKSO	11.38	N/A	N/A	0
2026-03-09	EKSO	12.02	N/A	N/A	0
2026-03-10	EKSO	12.4	N/A	N/A	0
2026-03-11	EKSO	12.75	N/A	N/A	0
2026-03-12	EKSO	11.75	N/A	N/A	0
2026-03-13	EKSO	11.81	N/A	N/A	0
2026-03-17	EKSO	10.79	N/A	N/A	0
2026-03-18	EKSO	10.51	N/A	N/A	0
2026-03-19	EKSO	10.4	N/A	N/A	0
2026-03-20	EKSO	10.56	N/A	N/A	0
2026-03-23	EKSO	10.56	N/A	N/A	0
2026-03-24	EKSO	10.48	N/A	N/A	0
2026-03-25	EKSO	10.9	N/A	N/A	0
2026-03-26	EKSO	10.87	N/A	N/A	0
2026-03-27	EKSO	10.18	N/A	N/A	0
2026-03-30	EKSO	10	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	EKSO	10.22	-	-	-0.43
2026-03-03	EKSO	10.01	-	-	-0.43
2026-03-04	EKSO	10.80	-	-	-0.43
2026-03-05	EKSO	10.98	-	-	-0.43
2026-03-06	EKSO	11.43	-	-	-0.43
2026-03-09	EKSO	12.02	-	-	-0.43
2026-03-10	EKSO	12.40	-	-	-0.43
2026-03-11	EKSO	12.69	-	-	-0.43
2026-03-12	EKSO	11.89	-	-	-0.43
2026-03-13	EKSO	11.51	-	-	-0.43
2026-03-17	EKSO	10.91	-	-	-0.43
2026-03-18	EKSO	10.55	-	-	-0.43
2026-03-19	EKSO	10.50	-	-	-0.43
2026-03-20	EKSO	10.50	-	-	-0.43
2026-03-23	EKSO	10.70	-	-	-0.43
2026-03-24	EKSO	10.74	-	-	-0.43
2026-03-25	EKSO	10.99	-	-	-0.43
2026-03-26	EKSO	10.99	-	-	-0.43
2026-03-27	EKSO	10.12	-	-	-0.43
2026-03-30	EKSO	10.04	-	-	-0.43
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	EKSO	8.72	-0.45	10.46
2026-03-03	EKSO	8.72	-0.45	10.46
2026-03-04	EKSO	8.72	-0.45	10.46
2026-03-05	EKSO	8.72	-0.45	10.46
2026-03-06	EKSO	8.71	-0.45	10.46
2026-03-09	EKSO	8.72	-0.45	10.46
2026-03-10	EKSO	8.72	-0.45	10.46
2026-03-11	EKSO	8.72	-0.45	9.29
2026-03-12	EKSO	8.71	-0.45	9.29
2026-03-13	EKSO	8.72	-0.45	9.29
2026-03-17	EKSO	8.72	-0.45	9.29
2026-03-18	EKSO	8.72	-0.45	9.29
2026-03-19	EKSO	8.72	-0.45	9.29
2026-03-20	EKSO	8.72	-0.45	9.29
2026-03-23	EKSO	9.06	-0.47	9.29
2026-03-24	EKSO	9.06	-0.47	9.29
2026-03-25	EKSO	9.06	-0.47	10.03
2026-03-26	EKSO	9.06	-0.47	10.03
2026-03-27	EKSO	9.06	-0.47	10.03
2026-03-30	EKSO	9.06	-0.47	10.03
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-1.56

Avg. EPS Est. Current Quarter

-0.23

Avg. EPS Est. Next Quarter

-0.15

Insider Transactions

9.06

Institutional Transactions

-0.47

Beta

0.78

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

90.7

Max Drawdown 5-Year %

-97.3

Target Price

49.75

P/E

Forward P/E

PEG

P/S

2.79

P/B

3.95

P/Free Cash Flow

EPS

-5.06

Average EPS Est. Cur. Y

-0.43

EPS Next Y. (Est.)

-0.07

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-91.37

Relative Volume

0.01

Return on Equity vs Sector %

-157

Return on Equity vs Industry %

-139.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ EKSO Healthcare

$10.03

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

6/20

Pullback

22/25

Volume

11/15

Valuation

10/20

TP/AR

1/10

Options

0/10

RSI

44.1

Range 1M

6.5%

Sup Dist

2.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

21/30

Estimates

0/20

Inst/Vol

4/15

Options

0/10

EPS Yr

74.5%

EPS NY

80.8%

52W%

68.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +396% upside

Quality

5/30

Valuation

16/30

Growth

15/25

Stability

5/10

LT Trend

1/5

Upside

+396%

Quality

Ekso Bionics Holdings, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 50

Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

EKSO

Latest News

—

Caricamento notizie per EKSO…

stock quote shares EKSO – Ekso Bionics Holdings Inc. Stock Price stock today

news today EKSO – Ekso Bionics Holdings Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch EKSO – Ekso Bionics Holdings Inc. yahoo finance google finance

stock history EKSO – Ekso Bionics Holdings Inc. invest stock market

stock prices EKSO premarket after hours

ticker EKSO fair value insiders trading

MDLN – Medline Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MDLN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

SOLV – Solventum Corp

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SOLV

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y